Stoll Dermatology
Beverly Hills, California, United States
Dermatologist in Beverly Hills, California
9735 Wilshire Blvd Suite #418, Beverly Hills, CA 90212
About Stoll Dermatology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Janssen Research & Development, LLC
2
Clinical Trials at Stoll Dermatology
During the past decade, Stoll Dermatology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis
2015-08-01
2017-08-03
Completed
1,257
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
2018-06-26
2020-06-03
Completed
1,484
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
2022-07-13
2025-07-10
Recruiting
200
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
2022-06-13
2023-03-23
Active, not recruiting
90
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Stoll Dermatology
According to Clinical.Site data, the most researched conditions in "Stoll Dermatology" are
"Plaque Psoriasis" (3 trials), "Psoriasis" (1 trials) and "Scalp Psoriasis" (1 trials). Many other conditions were trialed in "Stoll Dermatology" in a lesser frequency.
Clinical Trials Intervention Types at Stoll Dermatology
Most popular intervention types in "Stoll Dermatology" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (1 trials), "Ixekizumab" (1 trials), "JNJ-77242113" (1 trials) and "Mirikizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Stoll Dermatology
The vast majority of trials in "Stoll Dermatology" are
4 trials for "All" genders.
Clinical Trials Status at Stoll Dermatology
Currently, there are NaN active trials in "Stoll Dermatology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Stoll Dermatology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stoll Dermatology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".